greeksoup/ stock research

Healthstream (HSTM) FY2024 results: revenue $292 million, up 4.5% on the year

Healthstream Inc. (HSTM) reported revenue of $292 million for fiscal 2024, the year ended 31 December 2024, up 4.5% on the year before. Net income was $20 million, up 31.5%, and diluted earnings per share $0.66. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2025.

Revenue
$292 million
+4.5% on the year
FY2017FY2024
Operating margin
7.3%
5.7% a year earlier
FY2017FY2024
Net income
$20 million
+31.5% on the year
FY2017FY2024
Diluted EPS
$0.66
+32.0% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue292279267+4.5%
Cost of revenue97.995.091.1+3.1%
Gross profit194184176+5.3%
Gross margin66.4%65.9%65.8%
Research and development48.945.544.3+7.4%
Operating income21.316.012.4+32.9%
Operating margin7.3%5.7%4.7%
Pre-tax income24.818.515.6+34.0%
Income tax4.83.33.5+45.4%
Effective tax rate19.3%17.8%22.4%
Net income20.015.212.1+31.5%
Net margin6.9%5.5%4.5%
Diluted EPS$0.66$0.50$0.39+32.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow57.764.051.2-9.9%
Capital expenditure1.42.21.8-36.3%
Free cash flow56.361.849.4-8.9%
Free cash flow margin19.3%22.1%18.5%
Cash from investing-34.0-56.6-28.4
Cash from financing-4.5-13.0-23.7
Depreciation and amortisation41.241.137.9+0.4%
Share-based compensation4.54.23.6+7.6%
Buybacks0.08.923.1
Dividends paid3.43.10.0+11.3%
Dividend per share$0.11$0.10$0.00+12.0%
Diluted shares, weighted31m31m31m-0.4%
Shares outstanding at period end30m30m31m+0.4%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity359341334+5.5%
Debt0.00.00.0
Operating lease liabilities17.420.223.3-14.2%
Other liabilities134139140-3.5%
Total liabilities and equity511500498+2.2%
Fixed assets10.713.015.5-17.4%
Goodwill191191192-0.1%
Intangible assets55.568.081.6-18.3%
Investments37.730.87.9+22.6%
Cash and equivalents59.540.346.0+47.4%
Receivables30.234.336.7-12.1%
Other assets126122118+3.1%
Total assets511500498+2.2%

10-K for the year ended 31 December 2024, filed 28 February 2025: the filing.